Predict your next investment

HEALTHCARE | Medical Devices & Equipment
nanoporetech.com

See what CB Insights has to offer

Competitors

4

Business Relationships

10

Oxford Nanopore Technologies Competitors & Alternatives

4 Competitors

Oxford Nanopore Technologies has 4 competitors. Oxford Nanopore Technologies's competitors are Pacific Biosciences and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

2/10/2021

Corporate Minority - P2P

$376.62M

California

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

00/00/0000

Subscribe to see more

Subscribe to see more

$99M

Subscribe to see more

Latest Funding

2/10/2021

00/00/0000

00/00/0000

00/00/0000

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Investment Stage

Corporate Minority - P2P

Subscribe to see more

Subscribe to see more

Subscribe to see more

Total Funding

$376.62M

$99M

$99M

$99M

Mosaic

Location

California

Subscribe to see more

Subscribe to see more

Subscribe to see more

Oxford Nanopore Technologies Partners & Customers

10 Partners and customers

Oxford Nanopore Technologies has 10 strategic partners and customers. Oxford Nanopore Technologies recently partnered with Avantor on August 8, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

8/16/2021

Licensee

Avantor

United States

Oxford Nanopore Technologies Inks Distribution Agreement With Avantor for North America, Europe

NEW YORK -- Oxford Nanopore Technologies said on Monday that it has signed a distribution agreement for its MinIon nanopore sequencing devices and consumables with Avantor , a provider of technologies and services to the biopharma , healthcare , education and government , and applied materials industries .

2

1/12/2021

Licensor

NVIDIA

United States

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA A100 into Oxford Nanopore Technologies 's ultra-high throughput sequencing system , PromethION .

1

12/15/2020

Licensee

Source BioScience

United Kingdom

Oxford Nanopore Technologies Ltd - Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service – IP Group plc

Oxford Nanopore Technologies Limited , a leading next generation DNA/RNA sequencing technology company and SourceBio , an international provider of integrated state of the art laboratory services and products , announce a strategic commercial partnership to offer a commercially available COVID-19 testing solution to corporate customers wishing to provide high quality testing to their employees or other stakeholders , at scale .

2

9/22/2020

Licensor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

6/9/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

8/16/2021

1/12/2021

12/15/2020

9/22/2020

6/9/2020

Type

Licensee

Licensor

Licensee

Licensor

Partner

Business Partner

Avantor

NVIDIA

Source BioScience

Country

United States

United States

United Kingdom

Subscribe to see more

Subscribe to see more

News Snippet

Oxford Nanopore Technologies Inks Distribution Agreement With Avantor for North America, Europe

NEW YORK -- Oxford Nanopore Technologies said on Monday that it has signed a distribution agreement for its MinIon nanopore sequencing devices and consumables with Avantor , a provider of technologies and services to the biopharma , healthcare , education and government , and applied materials industries .

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA A100 into Oxford Nanopore Technologies 's ultra-high throughput sequencing system , PromethION .

Oxford Nanopore Technologies Ltd - Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service – IP Group plc

Oxford Nanopore Technologies Limited , a leading next generation DNA/RNA sequencing technology company and SourceBio , an international provider of integrated state of the art laboratory services and products , announce a strategic commercial partnership to offer a commercially available COVID-19 testing solution to corporate customers wishing to provide high quality testing to their employees or other stakeholders , at scale .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

2

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.